RAP charting, page-2227

Milestones for 2016
Obtained approval to enroll adult patients at second hospital site, The Wesley Hospital (Q1) ¨
Reported interim results from pediatric study demonstrating superiority to stethoscope for lower respiratory tract disease (Q1) ¨
Secured partnership with global humanitarian organisation for developing world trial (Q1) ¨
Successfully held Pre-Submission meeting with the US FDA (Q1) ¨
Report updated results from pediatric clinical study (Q1) ¨
Report preliminary results from adult clinical study (Q2) ¨
Initiate pivotal clinical study in US and Australia (Q2) ¨
File de novo premarket submission with FDA for first ResApp product (mid-year) ¨
FDA marketing approval for first ResApp product (Q4)


i think it really needs to hold this 255/260 point or could take a bit of a dive.